Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cesana, C.
Right arrow Articles by Rizzoli, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cesana, C.
Right arrow Articles by Rizzoli, V.
Stem Cells, Vol. 15, No. 3, 207-213, May 1997
© 1997 AlphaMed Press

In Vitro Growth of Mobilized Peripheral Blood Progenitor Cells is Significantly Enhanced by Stem Cell Factor

Clara Cesana, Carmelo Carlo-Stella, Lina Mangoni, Ester Regazzi, Daniela Garau, Gabriella Sammarelli, Cecilia Caramatti, Camillo Almici, Vittorio Rizzoli

Department of Hematology - Bone Marrow Transplantation Center, University of Parma, Parma, Italy

Key Words. Stem cell factor • Blood cell transplantation • Long-term culture initiating cells • Hematopoietic growth factors • G-CSF • Cyclophosphamide

Dr. Carmelo Carlo-Stella, Cattedra di Ematologia, Centro Trapianti di Midollo Osseo, Università di Parma, via Gramsci 14, 43100 Parma, Italy.

The existence of primitive hematopoietic progenitors in mobilized peripheral blood is suggested by clinical, phenotypic and in vitro cell culture evidences. In order to quantify primitive progenitors, 32 leukaphereses from 15 patients with lymphoid malignancies were investigated for the growth of multilineage colony-forming units (CFU-Mix), erythroid burst-forming units (BFU-E) and granulocyte-macrophage colony-forming units (CFU-GM) in the absence or presence of recombinant stem cell factor (SCF), a cytokine which selectively controls stem cell self-renewal, proliferation and differentiation. Primitive progenitors were also quantitated by means of a long-term assay which allows the growth of cells capable of initiating and sustaining hematopoiesis in long-term culture (LTC-IC). Addition of SCF (50 ng/ml) to methylcellulose cultures stimulated with maximal concentrations of G-CSF, GM-CSF, interleukin 3 and erythropoietin significantly increased the growth (mean ± SE) of CFU-Mix (7.7 ± 1.7 versus 2.4 ± 0.6, p <= 0.0001), BFU-E (47 ± 10 versus 32 ± 6, p <= 0.002) and CFU-GM (173 ± 31 versus 112 ± 20, p <= 0.0001). Mean (± SE) percentages of SCF-dependent CFU-Mix, BFU-E and CFU-GM were 60 ± 5%, 19 ± 5%, and 33 ± 4%, respectively. Mean (± SE) LTC-IC growth per 2 x 106 nucleated cells was 221 ± 53 (range, 2 to 704). Linear regression analysis demonstrated a statistically significant correlation (r = .87; p <= 0.0001) between LTC-IC and SCF-dependent progenitors. In conclusion, our data suggest that: A) the optimal quantification of mobilized progenitors requires supplementation of methylcellulose cultures with SCF, and B) in vitro detection of SCF-dependent progenitors might represent a reliable and technically simple method to assess the primitive progenitor cell content of blood cell autografts. Such in vitro evaluation of immature hematopoietic progenitors might be clinically relevant for predicting the reconstituting potential of autografts.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1997 by AlphaMed Press.